Protection from angiotensin II–mediated vasculotoxic and hypertensive response in mice lacking PI3Kγ
Male
Mice, Knockout
0301 basic medicine
Angiotensin II
hypertension; angiotensin; signal transduction; genetically modified mice
Article
Muscle, Smooth, Vascular
Mesenteric Arteries
3. Good health
Isoenzymes
Mice
Phosphatidylinositol 3-Kinases
03 medical and health sciences
Vasoconstriction
Hypertension
Animals
Vasoconstrictor Agents
Calcium
Reactive Oxygen Species
Angiotensin II; Animals; Aorta; Calcium; Cells, Cultured; Hypertension; Isoenzymes; Male; Mesenteric Arteries; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; Vasoconstriction; Vasoconstrictor Agents; Immunology and Allergy; Immunology
Aorta
Cells, Cultured
Phosphoinositide-3 Kinase Inhibitors
DOI:
10.1084/jem.20040995
Publication Date:
2005-04-12T00:23:47Z
AUTHORS (19)
ABSTRACT
Hypertension affects nearly 20% of the population in Western countries and strongly increases the risk for cardiovascular diseases. In the pathogenesis of hypertension, the vasoactive peptide of the renin-angiotensin system, angiotensin II and its G protein–coupled receptors (GPCRs), play a crucial role by eliciting reactive oxygen species (ROS) and mediating vessel contractility. Here we show that mice lacking the GPCR-activated phosphoinositide 3-kinase (PI3K)γ are protected from hypertension that is induced by administration of angiotensin II in vivo. PI3Kγ was found to play a role in angiotensin II–evoked smooth muscle contraction in two crucial, distinct signaling pathways. In response to angiotensin II, PI3Kγ was required for the activation of Rac and the subsequent triggering of ROS production. Conversely, PI3Kγ was necessary to activate protein kinase B/Akt, which, in turn, enhanced L-type Ca2+ channel–mediated extracellular Ca2+ entry. These data indicate that PI3Kγ is a key transducer of the intracellular signals that are evoked by angiotensin II and suggest that blocking PI3Kγ function might be exploited to improve therapeutic intervention on hypertension.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (122)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....